ALGS Annual D&A
$3.07 M
-$606.00 K-16.49%
31 December 2023
Summary:
As of January 23, 2025, ALGS annual depreciation & amortization is $3.07 million, with the most recent change of -$606.00 thousand (-16.49%) on December 31, 2023. During the last 3 years, it has fallen by -$256.00 thousand (-7.70%). ALGS annual D&A is now -18.77% below its all-time high of $3.78 million, reached on December 31, 2021.ALGS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALGS Quarterly D&A
$667.00 K
+$57.00 K+9.34%
30 September 2024
Summary:
As of January 23, 2025, ALGS quarterly depreciation & amortization is $667.00 thousand, with the most recent change of +$57.00 thousand (+9.34%) on September 30, 2024. Over the past year, it has dropped by -$108.00 thousand (-13.94%). ALGS quarterly D&A is now -39.20% below its all-time high of $1.10 million, reached on June 30, 2020.ALGS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALGS TTM D&A
$2.73 M
-$14.00 K-0.51%
30 September 2024
Summary:
As of January 23, 2025, ALGS TTM depreciation & amortization is $2.73 million, with the most recent change of -$14.00 thousand (-0.51%) on September 30, 2024. Over the past year, it has dropped by -$343.00 thousand (-11.18%). ALGS TTM D&A is now -29.89% below its all-time high of $3.89 million, reached on March 31, 2022.ALGS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALGS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.5% | -13.9% | -11.2% |
| 3 y3 years | -7.7% | -21.0% | -22.9% |
| 5 y5 years | - | -21.0% | -22.9% |
ALGS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | at low | -34.2% | +9.3% | -29.9% | at low |
| 5 y | 5-year | -18.8% | +33.5% | -39.2% | +45.0% | -29.9% | +492.6% |
| alltime | all time | -18.8% | +33.5% | -39.2% | +45.0% | -29.9% | +492.6% |
Aligos Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $667.00 K(+9.3%) | $2.73 M(-0.5%) |
| June 2024 | - | $610.00 K(-9.5%) | $2.74 M(-5.5%) |
| Mar 2024 | - | $674.00 K(-13.0%) | $2.90 M(-5.5%) |
| Dec 2023 | $3.07 M(-16.5%) | $775.00 K(+13.8%) | $3.07 M(-3.8%) |
| Sept 2023 | - | $681.00 K(-11.4%) | $3.19 M(-6.6%) |
| June 2023 | - | $769.00 K(-8.9%) | $3.42 M(-3.4%) |
| Mar 2023 | - | $844.00 K(-5.9%) | $3.54 M(-3.8%) |
| Dec 2022 | $3.67 M | $897.00 K(-1.0%) | $3.67 M(-3.1%) |
| Sept 2022 | - | $906.00 K(+1.9%) | $3.79 M(-1.6%) |
| June 2022 | - | $889.00 K(-9.6%) | $3.85 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $983.00 K(-3.0%) | $3.89 M(+2.9%) |
| Dec 2021 | $3.78 M(+13.6%) | $1.01 M(+4.8%) | $3.78 M(+3.6%) |
| Sept 2021 | - | $967.00 K(+4.5%) | $3.65 M(+2.3%) |
| June 2021 | - | $925.00 K(+6.0%) | $3.57 M(-4.6%) |
| Mar 2021 | - | $873.00 K(-1.1%) | $3.74 M(+12.4%) |
| Dec 2020 | $3.33 M(+44.6%) | $883.00 K(-0.2%) | $3.33 M(+36.2%) |
| Sept 2020 | - | $885.00 K(-19.3%) | $2.44 M(+56.8%) |
| June 2020 | - | $1.10 M(+138.5%) | $1.56 M(+238.5%) |
| Mar 2020 | - | $460.00 K | $460.00 K |
| Dec 2019 | $2.30 M | - | - |
FAQ
- What is Aligos Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Aligos Therapeutics?
- What is Aligos Therapeutics annual D&A year-on-year change?
- What is Aligos Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly D&A year-on-year change?
- What is Aligos Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Aligos Therapeutics?
- What is Aligos Therapeutics TTM D&A year-on-year change?
What is Aligos Therapeutics annual depreciation & amortization?
The current annual D&A of ALGS is $3.07 M
What is the all time high annual D&A for Aligos Therapeutics?
Aligos Therapeutics all-time high annual depreciation & amortization is $3.78 M
What is Aligos Therapeutics annual D&A year-on-year change?
Over the past year, ALGS annual depreciation & amortization has changed by -$606.00 K (-16.49%)
What is Aligos Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ALGS is $667.00 K
What is the all time high quarterly D&A for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly depreciation & amortization is $1.10 M
What is Aligos Therapeutics quarterly D&A year-on-year change?
Over the past year, ALGS quarterly depreciation & amortization has changed by -$108.00 K (-13.94%)
What is Aligos Therapeutics TTM depreciation & amortization?
The current TTM D&A of ALGS is $2.73 M
What is the all time high TTM D&A for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM depreciation & amortization is $3.89 M
What is Aligos Therapeutics TTM D&A year-on-year change?
Over the past year, ALGS TTM depreciation & amortization has changed by -$343.00 K (-11.18%)